Sen. Bill Cassidy (R-LA) (J. Scott Applewhite/AP Images)

Sen­ate un­veils its ver­sion of ac­cel­er­at­ed ap­proval re­forms as bi­par­ti­san duo calls on FDA and PTO to work to­geth­er

The Sen­ate is join­ing its House coun­ter­parts and ad­vanc­ing ac­cel­er­at­ed ap­proval path­way re­forms to the FDA user fee leg­is­la­tion that must be signed by Pres­i­dent Joe Biden be­fore the end of Sep­tem­ber or else the FDA will have to start lay­ing off its staff.

While Sen. Richard Burr (R-NC) warned yes­ter­day that the user fee deals could be de­layed by the in­fant for­mu­la cri­sis, the new­ly in­tro­duced bill on Fri­day shows how the Sen­ate is align­ing with its House coun­ter­parts on sim­i­lar ac­cel­er­at­ed ap­proval re­forms.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.